Angioimmunoblastic T-cell lymphoma laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Laboratory tests for angioimmunoblastic T-cell lymphoma include [[complete blood count]] (CBC), polyclonal hyperglobulinemia, [[FISH]], [[immunohistochemistry]], and [[immunophenotyping]].
Laboratory tests for angioimmunoblastic T-cell lymphoma include [[complete blood count]] (CBC), polyclonal hyperglobulinemia, [[FISH]], [[immunohistochemistry]], and [[immunophenotyping]].<ref name= seer >Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015</ref>
==Laboratory Tests==
==Laboratory Tests==
Laboratory tests for angioimmunoblastic T-cell lymphoma include:
Laboratory tests for angioimmunoblastic T-cell lymphoma include:<ref name= seer >Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015</ref>
* [[Complete blood count]] (CBC)
* [[Complete blood count]] (CBC)
:* [[Anemia]]
:* [[Anemia]]
:* [[Eosinophilia]]
:* [[Eosinophilia]]
* Polyclonal [[hypergammaglobulinemia]]
* Polyclonal [[hypergammaglobulinemia]]
* Blood chemistry studies
* [[Flow cytometry]]
* [[Immunohistochemistry]]
* Fluorescence in situ hybridization ([[FISH]])
* Fluorescence in situ hybridization ([[FISH]])
:* Negative for the Epstein-Barr virus ([[EBV]])
:* Negative for the Epstein-Barr virus ([[EBV]])
* Immunophenotyping
* Immunophenotyping
:* Positivity for [[CD2]], [[CD3]], [[CD4]], [[CD5]], [[CD20]] and focal positivity for [[CXCL13]]  
:* Positivity for [[CD2]], [[CD3]], [[CD4]], [[CD5]], [[CD10]], [[CD20]] and focal positivity for [[CXCL13]]  
:* Negative for ALK1 and [[CD30]]
:* Negative for ALK1 and [[CD30]]
==References==
==References==

Revision as of 13:54, 27 November 2015

Angioimmunoblastic T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Biopsy

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angioimmunoblastic T-cell lymphoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angioimmunoblastic T-cell lymphoma laboratory tests

CDC on Angioimmunoblastic T-cell lymphoma laboratory tests

Angioimmunoblastic T-cell lymphoma laboratory tests in the news

Blogs on Angioimmunoblastic T-cell lymphoma laboratory tests

Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma

Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Laboratory tests for angioimmunoblastic T-cell lymphoma include complete blood count (CBC), polyclonal hyperglobulinemia, FISH, immunohistochemistry, and immunophenotyping.[1]

Laboratory Tests

Laboratory tests for angioimmunoblastic T-cell lymphoma include:[1]

  • Negative for the Epstein-Barr virus (EBV)
  • Immunophenotyping

References

  1. 1.0 1.1 Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015

Template:WH Template:WS